JOHN J. ORLOFF - 12 Sep 2024 Form 3 Insider Report for Zenas BioPharma, Inc. (ZBIO)

Role
Director
Signature
By: /s/ Chase Jayasekera, Attorney-in-Fact
Issuer symbol
ZBIO
Transactions as of
12 Sep 2024
Transactions value $
$0
Form type
3
Filing time
12 Sep 2024, 21:43:45 UTC
Previous filing
23 Jul 2021
Next filing
12 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZBIO Stock Option (Right to Buy) 12 Sep 2024 Common Stock 5.76K $7.82 Direct F1
holding ZBIO Stock Option (Right to Buy) 12 Sep 2024 Common Stock 11.5K $9.30 Direct F2
holding ZBIO Stock Option (Right to Buy) 12 Sep 2024 Common Stock 23K $11.90 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal annual installments over three years beginning on December 16, 2022, the first anniversary of the vesting commencement date, subject to continued service.
F2 The option vests in equal annual installments over three years beginning on February 21, 2024, the first anniversary of the vesting commencement date, subject to continued service.
F3 The option vests in equal annual installments over three years beginning on February 27, 2025, the first anniversary of the vesting commencement date, subject to continued service.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney